Santa Cruz Biotechnology is a world leader in the development of products for the biomedical research market. Over the past twenty years, the Company has focused on the ongoing development of research monoclonal antibodies, biochemicals, labware and CRISPR products. Santa Cruz Biotechnology has the highest commitment to quality and customer service.

Santa Cruz Biotechnology offers monoclonal antibodies directed against a broad range of mammalian and non-mammalian protein targets. To locate any antibody of interest, either refer to the functional groupings listed below or go to the search bar above to locate antibodies by product name, catalog number, keyword, protein name.

Over 8,300 of our most popular antibodies are also available as ImmunoCruz® Conjugates, including AC, HRP, PE, FITC, Alexa Fluor® 488, 546, 594, 647, 680, and 790 conjugates for direct Western Blotting and Staining applications, eliminating the need for a secondary antibody. Additional conjugates are also available for many antibodies, including Biotin, TRITC, PE-Cy5, PE-Cy7, APC, APC-Cy7, Alexa Fluor® 405, PerCP and PerCP-Cy5.5.

Santa Cruz Biotechnology now offers target-specific CRISPR/Cas9 Knockout (KO) Plasmids, CRISPR Double Nickase Plasmids, CRISPR/dCas9 Activation Plasmids and CRISPR Lenti Activation Systems for over 18,910 human and 18,340 mouse protein encoding genes. CRISPR/Cas9 KO Plasmids and CRISPR Double Nickase Plasmids enable the identification and cleavage of specific genes encoding a protein of interest thereby eliminating production of that gene product (protein). CRISPR/dCas9 Activation Plasmids and CRISPR Lenti Activation Systems activate endogenous gene transcription using a robust synergistic activation mediator (SAM) system. This exciting new technology is a useful tool for studying protein function and signaling pathways.